Your browser doesn't support javascript.
loading
Bioequivalence and Safety of Levetiracetam Granules and Oral Solution: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under a Fasting Condition.
Liu, Yun; Zou, Yang; Wang, Yijun; Jiang, Fan; Xu, Wenjing; Liu, Shuyun; Jia, Jingying; Yu, Chen; Fang, Liming; Hu, Liwei; Zhang, Kanyin E; Long, Jingwen; Pu, Huahua.
Afiliação
  • Liu Y; Central Laboratory, Shanghai Xuhui Central Hospital/Zhongshan-Xuhui Hospital, Fudan University, Shanghai, People's Republic of China.
  • Zou Y; Shanghai Engineering Research Center of Phase I Clinical Research, Quality Consistency Evaluation for Drugs, Shanghai, People's Republic of China.
  • Wang Y; Central Laboratory, Shanghai Xuhui Central Hospital/Zhongshan-Xuhui Hospital, Fudan University, Shanghai, People's Republic of China.
  • Jiang F; Shanghai Engineering Research Center of Phase I Clinical Research, Quality Consistency Evaluation for Drugs, Shanghai, People's Republic of China.
  • Xu W; Central Laboratory, Shanghai Xuhui Central Hospital/Zhongshan-Xuhui Hospital, Fudan University, Shanghai, People's Republic of China.
  • Liu S; Shanghai Engineering Research Center of Phase I Clinical Research, Quality Consistency Evaluation for Drugs, Shanghai, People's Republic of China.
  • Jia J; Central Laboratory, Shanghai Xuhui Central Hospital/Zhongshan-Xuhui Hospital, Fudan University, Shanghai, People's Republic of China.
  • Yu C; Shanghai Engineering Research Center of Phase I Clinical Research, Quality Consistency Evaluation for Drugs, Shanghai, People's Republic of China.
  • Fang L; Central Laboratory, Shanghai Xuhui Central Hospital/Zhongshan-Xuhui Hospital, Fudan University, Shanghai, People's Republic of China.
  • Hu L; Shanghai Engineering Research Center of Phase I Clinical Research, Quality Consistency Evaluation for Drugs, Shanghai, People's Republic of China.
  • Zhang KE; Central Laboratory, Shanghai Xuhui Central Hospital/Zhongshan-Xuhui Hospital, Fudan University, Shanghai, People's Republic of China.
  • Long J; Shanghai Engineering Research Center of Phase I Clinical Research, Quality Consistency Evaluation for Drugs, Shanghai, People's Republic of China.
  • Pu H; Central Laboratory, Shanghai Xuhui Central Hospital/Zhongshan-Xuhui Hospital, Fudan University, Shanghai, People's Republic of China.
Clin Pharmacol Drug Dev ; 11(3): 372-378, 2022 03.
Article em En | MEDLINE | ID: mdl-35157781

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Jejum Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Jejum Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos